Safety Study of Botulinum Toxin Type A for the Treatment of Focal Upper Limb Poststroke Spasticity

Completed

Phase 2 Results N/A

Eligibility Criteria

Inclusion Criteria

- Medically stable poststroke patients with spastic muscles in the upper limb

Exclusion Criteria

- Stroke within 6 months of study enrollment
- Previous therapy with Botulinum Toxin Type A for treatment of any condition prior to 4 months of enrollment, for treatment of any condition prior to 01 January 1998